Ferrari Raffaele, Lupi Monica, Colombo Claudio, Morbidelli Massimo, D'Incalci Maurizio, Moscatelli Davide
Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.
Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milano, Italy.
Colloids Surf B Biointerfaces. 2014 Nov 1;123:639-47. doi: 10.1016/j.colsurfb.2014.10.003. Epub 2014 Oct 13.
In this work a large number of polymer nanoparticles (NPs) with different features have been synthesized through emulsion polymerization-based methods. Poly(methyl methacrylate) (PMMA), poly-ɛ-caprolactone (PCL), and poly(lactic acid) (PLA) based NPs with different size, hydrophobicity, surface charge, PEGylation degree, type of emulsifier and ζ potential have been produced and characterized. All the different NPs have been adopted for cellular uptake studies, leading to a precise quantification of the number of internalized NPs into a selected tumor cell line. The experiments summarize, emphasize and improve the comprehension of the influence of NPs features on the uptake efficiency. In detail, a linear relationship between uptake and both size and NP concentration independently upon other NP characteristics was found. Moreover, it was confirmed that cells are able to internalize and retain for a long time preferentially positively charged NPs. Finally, by coupling results of uptake studies with cell viability measurements, an easy and fast check to control the effectiveness of a selected polymer as drug carrier has been proposed. In particular, we observed that biodegradable PLA-based NPs with high molecular weight, non-PEGylated and positively charged PCL NPs are the better choice to maximize the uptake and minimize side effect against cells.
在这项工作中,通过基于乳液聚合的方法合成了大量具有不同特性的聚合物纳米颗粒(NPs)。制备并表征了基于聚甲基丙烯酸甲酯(PMMA)、聚己内酯(PCL)和聚乳酸(PLA)的具有不同尺寸、疏水性、表面电荷、聚乙二醇化程度、乳化剂类型和ζ电位的纳米颗粒。所有不同的纳米颗粒都被用于细胞摄取研究,从而精确量化内化到选定肿瘤细胞系中的纳米颗粒数量。这些实验总结、强调并增进了对纳米颗粒特性对摄取效率影响的理解。具体而言,发现摄取与尺寸和纳米颗粒浓度之间存在线性关系,且不受其他纳米颗粒特性的影响。此外,证实细胞能够优先内化并长时间保留带正电荷的纳米颗粒。最后,通过将摄取研究结果与细胞活力测量结果相结合,提出了一种简单快速的方法来检验所选聚合物作为药物载体的有效性。特别是,我们观察到高分子量、非聚乙二醇化且带正电荷的基于聚乳酸的可生物降解纳米颗粒以及基于聚己内酯的纳米颗粒是最大化摄取并最小化对细胞副作用的更佳选择。